CTI BioPharma Net Income 2006-2020 | CTIC

CTI BioPharma net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
CTI BioPharma Annual Net Income
(Millions of US $)
2019 $-40
2018 $-29
2017 $-45
2016 $-52
2015 $-123
2014 $-96
2013 $-50
2012 $-115
2011 $-121
2010 $-148
2009 $-117
2008 $-203
2007 $-148
2006 $-136
2005 $-103
CTI BioPharma Quarterly Net Income
(Millions of US $)
2020-06-30 $-14
2020-03-31 $-12
2019-12-31 $-8
2019-09-30 $-10
2019-06-30 $-11
2019-03-31 $-11
2018-12-31 $1
2018-09-30 $-15
2018-06-30 $-11
2018-03-31 $-4
2017-12-31 $-14
2017-09-30 $-12
2017-06-30 $1
2017-03-31 $-20
2016-12-31 $-6
2016-09-30 $-29
2016-06-30 $-20
2016-03-31 $3
2015-12-31 $-29
2015-09-30 $-33
2015-06-30 $-33
2015-03-31 $-29
2014-12-31 $-44
2014-09-30 $5
2014-06-30 $-27
2014-03-31 $-29
2013-12-31 $10
2013-09-30 $-22
2013-06-30 $-18
2013-03-31 $-19
2012-12-31 $-19
2012-09-30 $-20
2012-06-30 $-59
2012-03-31 $-17
2011-12-31 $-18
2011-09-30 $-30
2011-06-30 $-23
2011-03-31 $-51
2010-12-31 $-34
2010-09-30 $-16
2010-06-30 $-54
2010-03-31 $-44
2009-12-31 $-27
2009-09-30 $-49
2009-06-30 $-27
2009-03-31 $-13
2008-12-31 $-41
2008-09-30 $-48
2008-06-30 $-59
2008-03-31 $-55
2007-12-31 $-39
2007-09-30 $-53
2007-06-30 $-28
2007-03-31 $-29
2006-12-31 $-36
2006-09-30 $-28
2006-06-30 $-20
2006-03-31 $-52
2005-12-31 $-19
2005-09-30 $-9
2005-06-30 $-36
2005-03-31 $-39
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.092B $0.003B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.486B 42.94
Takeda Pharmaceutical (TAK) Japan $58.483B 10.19
Astellas Pharma (ALPMY) Japan $30.589B 15.50
Eisai (ESALY) Japan $26.024B 21.99
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.609B 23.09
Catalent (CTLT) United States $13.694B 52.94
Grifols, S.A (GRFS) Spain $12.630B 15.44
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.700B 41.42
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.417B 46.98
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.828B 11.30
United Therapeutics (UTHR) United States $4.858B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $4.369B 0.00
FibroGen (FGEN) United States $4.076B 0.00
Evotec AG (EVTCY) Germany $3.967B 137.87
Hypermarcas (HYPMY) Brazil $3.914B 14.40
ChemoCentryx (CCXI) United States $3.666B 0.00
Nektar Therapeutics (NKTR) United States $3.587B 0.00
PTC Therapeutics (PTCT) United States $3.351B 0.00
Sage Therapeutics (SAGE) United States $2.613B 0.00
Pacira BioSciences (PCRX) United States $2.594B 68.18
Taro Pharmaceutical Industries (TARO) Israel $2.414B 11.69
Cronos Group (CRON) Canada $2.008B 0.00
Xencor (XNCR) United States $1.910B 0.00
Revolution Medicines (RVMD) United States $1.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.786B 0.00
USANA Health Sciences (USNA) United States $1.759B 16.57
Ironwood Pharmaceuticals (IRWD) United States $1.630B 11.37
Indivior (INVVY) United States $1.606B 19.91
Corcept Therapeutics (CORT) United States $1.583B 14.57
Akebia Therapeutics (AKBA) United States $1.523B 0.00
Heron Therapeutics (HRTX) United States $1.439B 0.00
Zogenix (ZGNX) United States $1.376B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.280B 12.20
Karyopharm Therapeutics (KPTI) United States $1.114B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.075B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 619.63
VAXART, INC (VXRT) United States $0.993B 0.00
Esperion Therapeutics (ESPR) United States $0.924B 0.00
Tilray (TLRY) Canada $0.880B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.812B 0.00
Altimmune (ALT) United States $0.780B 0.00
Trillium Therapeutics (TRIL) Canada $0.754B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.717B 1.06
ImmunoGen (IMGN) United States $0.669B 0.00
Collegium Pharmaceutical (COLL) United States $0.619B 0.00
Flexion Therapeutics (FLXN) United States $0.604B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.599B 0.00
Molecular Templates (MTEM) United States $0.590B 0.00
Aerie Pharmaceuticals (AERI) United States $0.576B 0.00
Siga Technologies (SIGA) United States $0.566B 60.42
Radius Health (RDUS) United States $0.562B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.551B 0.00
Ocular Therapeutix (OCUL) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.507B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.491B 24.47
DURECT (DRRX) United States $0.461B 0.00
Organogenesis Holdings (ORGO) United States $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.424B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.353B 8.74
IMV INC (IMV) Canada $0.316B 0.00
Heat Biologics (HTBX) United States $0.312B 0.00
OptiNose (OPTN) United States $0.312B 0.00
Harpoon Therapeutics (HARP) United States $0.311B 0.00
MEI Pharma (MEIP) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.301B 0.00
Calithera Biosciences (CALA) United States $0.301B 0.00
Redhill Biopharma (RDHL) Israel $0.295B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Rafael Holdings (RFL) United States $0.281B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.266B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
Nivalis Therapeutics (ALPN) United States $0.223B 0.00
Aquestive Therapeutics (AQST) United States $0.223B 0.00
KalVista Pharmaceuticals (KALV) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.220B 21.71
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Onconova Therapeutics (ONTX) United States $0.181B 0.00
Xeris Pharmaceuticals (XERS) United States $0.170B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 7.77
Otonomy (OTIC) United States $0.163B 0.00
Lipocine (LPCN) United States $0.136B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
India Globalization Capital (IGC) United States $0.105B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Biomerica (BMRA) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.094B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Addex Therapeutics (ADXN) Switzerland $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.075B 0.00
Sundial Growers (SNDL) Canada $0.074B 0.00
Recro Pharma (REPH) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
PolarityTE (PTE) United States $0.057B 0.00
GTx (ONCT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Natural Alternatives (NAII) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
IsoRay (ISR) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.07
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.032B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Vical (BBI) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 21.31
Flex Pharma (SLRX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00